Home › Regeneron Pharmaceuticals PT Raised to $344.00
 

Keywords :   


Regeneron Pharmaceuticals PT Raised to $344.00

2013-12-22 08:42:25| Biotech - Topix.net

The firm currently has an "outperform" rating on the stock. RBC Capital's price target would indicate a potential upside of 23.43% from the company's current price.

Tags: raised pharmaceuticals regeneron regeneron pharmaceuticals

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
27.11 ( #1670 )
27.1117 AIR AGS 83M-S
27.11 XYZ 3
27.11XVSecret1
27.11NFT ADVANCE 3-370!
27.11 101
27.11
27.11 DESCENTE L
More »